Location: Dallas, TX
CIK: 0002043476 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value: $130M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ADMA | ADMA BIOLOGICS INC | 2,317,542 | $42.2M | 32.5% | $18.79 | +8.5% | COM | 000899104 |
| INSM | INSMED INC | 155,000 | $15.6M | 12.0% | $72.02 | +6.2% | COM PAR $.01 | 457669307 |
| ZLAB | ZAI LAB LTD | 400,000 | $13.99M | 10.8% | $26.19 | — | ADR | 98887Q104 |
| — | AKERO THERAPEUTICS INC | 232,446 | $12.4M | 9.5% | $27.82 | — | COM | 00973Y108 |
| — | ELI LILLY & CO | 15,000 | $11.69M | 9.0% | — | — | Put | 532457958 |
| CLLS | CELLECTIS S A | 3,256,501 | $4.966M | 3.8% | $1.77 | — | SPON ADS | 15117K103 |
| TSHA | TAYSHA GENE THERAPIES INC | 1,800,556 | $4.159M | 3.2% | $2.04 | +6.5% | COM SHS | 877619106 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 110,000 | $4M | 3.1% | $39.00 | -7.6% | COM | 90400D108 |
| SGHT | SIGHT SCIENCES INC | 930,000 | $3.841M | 3.0% | $4.05 | -17.5% | COM | 82657M105 |
| AURA | AURA BIOSCIENCES INC | 572,576 | $3.584M | 2.8% | $8.79 | -33.5% | COM | 05153U107 |
| ASMB | ASSEMBLY BIOSCIENCES INC | 189,350 | $3.431M | 2.6% | $13.84 | -4.7% | COM NEW | 045396207 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 1,500,000 | $2.58M | 2.0% | $7.88 | -68.4% | COM | 462260100 |
| — | ULTRAGENYX PHARMACEUTICAL IN | 67,600 | $2.458M | 1.9% | — | — | Call | 90400D908 |
| APGE | APOGEE THERAPEUTICS INC | 35,000 | $1.52M | 1.2% | $43.86 | -13.3% | COM | 03770N101 |
| PRAX | PRAXIS PRECISION MEDICINES I | 35,000 | $1.472M | 1.1% | $51.31 | -25.8% | COM NEW | 74006W207 |
| SYRE | SPYRE THERAPEUTICS INC | 80,000 | $1.198M | 0.9% | $25.38 | -41.7% | COM NEW | 00773J202 |
| ORKA | ORUKA THERAPEUTICS INC | 75,000 | $841K | 0.6% | $15.19 | -31.4% | COM | 687604108 |